Search tips
ESCMID Global 2024
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
10 July 2021 - 2032
Anti-influenza immunoglobulin (FLU-IVIG) in hospitalised patients with serious influenza A
Amy Dahl, A. Dahl (1), C. L. Hall (1), D. M. Anderson (1), P.A. De Lame (1), T. Babinchak (2), M. G. Ison (3), A. Torres (4)
10 July 2021 - 4568
Impact on in-hospital mortality of ceftaroline versus standard of care in community-acquired pneumonia: a propensity matched analysis
Catia Cilloniz, C. Cilloniz (1), R. Mendez (2), H. Peroni (3), C. Garcia-Vidal (4), V. Rico Caballero (4), R. Menendez (2), A. Torres (4), A. Soriano (4)
09 July 2021 - 3128
Incidence and characteristics of ventilator-associated pneumonia patients with COVID-19: a multi-centre study
Ana Motos Galera, A. Motos Galera (1, 2), A. Torres (1
09 July 2021 - 314
The value of C-reactive protein-to-lymphocyte ratio in predicting the severity of SARS Coronavirus 2 (SARS-CoV-2) pneumonia
Catia Cilloniz, C. Cilloniz Campos, C. Garcia-Vidal, V. Robles, C. Domingo, R. Muñoz, J.L. Bedini, A. Soriano, A. Torres
09 July 2021 - 315
Sepsis in relation to lymphopaenia in community-acquired pneumonia
Catia Cilloniz, C. Cilloniz Campos (1), H. Peroni (2), V. Robles (1), C. Domingo (1), R. Muñoz (1), J.L. Bedini (1), O. Patricia (1), A. Torres (1)
09 July 2021 - 1951
Differences in pneumococcal serotype distribution in hospitalised adults with community-acquired pneumonia between Spain and Greece (CAPA & EGNATIA studies), 2017-2019: could different PCV13 vaccination policies account?
Adamantia Liapikou, A. Liapikou (1, 2), R. Menéndez (3), A. Torres (4), P.P. España (5), J.A. Fernández-Villar (6), M. Toumbis (1), E. Begier (7), I. Cifuentes (8), C. Mendez (8), V. Kossyvaki (9), I. Zografaki (9), J. Skiadas (9), B. Gessner (7)
09 July 2021 - 1317
Evolution and distribution of pneumococcal serotypes in adults hospitalised with community-acquired pneumonia (CAP) in Spain from 2011 to 2018 using the UAD1/2 test: the CAPA study
Pedro Pablo España, P.P. España (1), R. Menéndez (2), A. Torres (3), J.A. Fernández-Villar (4), J.M. Marimón (5), A.P. Martínez De La Fuente (1), J.L. López-Hontangas (2), F. Marco (3), F.J. Vasallo (4), M. Ercibengoa (5), C. Méndez (6), I. Cifuentes (6), B.D. Gessner (7)
24 April 2018 - O1037
Twenty-year trend in mortality among hospitalized patients with pneumococcal community acquired pneumonia
Adamantia Liapikou, C. Cilloniz Campos, A. Liapikou, I. Martin-Loeches, C. Garcia Vidal, A. Ceccato, J. Mensa, C. Cardozo, F. Marco Reverte, A. Torres
24 April 2018 - O1033
Vaccine serotypes causing pneumococcal CAP in adults in Spain including UAD test (the CAPA study)
Sheila Bianca Buijs, P. España, R. Menendez, A. Torres, J. Fernández Villar, J. Marimon, A. Martínez de la Fuente, J. López-Hontangas, F. Marco Reverte, F. Vasallo Vidal, M. Ercibengoa0, I. Cifuentes, C. Méndez
23 April 2018 - P1454
The biofilm ring test, a rapid method for routine analysis of Pseudomonas aeruginosa in sputum from bronchiectasis patients with and without COPD
Thierry Naas, L. Fernandez-Barat, A. Motos, V. Alcaraz, R. Amaro, A. Ceccato, L. Bueno, A. Clement, C. Provot, J. Puig de la Bellacasa, N. Vázquez Burgos, L. Muñoz, J. Vila, A. Torres
22 April 2018 - O0602
Cost-effectiveness of ceftazidime/avibactam (CAZ-AVI) comparing to meropenem as an empiric treatment for hospital acquired pneumonia including ventilator-associated pneumonia (HAP/VAP)
Claudie Charbonneau, E. TICHY, A. Torres, M. Bassetti, T. Kongnakorn, R. Di Virgilio, P. Irani, C. Charbonneau
22 April 2018 - P0635
Costs and consequences of ceftaroline fosamil for the treatment of community-acquired pneumonia in hospitalized adults in Spain
Sheila Bianca Buijs, A. Torres, M. Bassetti, T. Welte, S. Rivolo, E. Remak, C. Peral, C. Charbonneau, J. Hammond, W. Ansari, S. Grau0
22 April 2018 - O0424
A phase-3, randomized, double-blind, multicentre study to evaluate the safety and efficacy of intravenous iclaprim versus vancomycin in the treatment of acute bacterial skin and skin structure infections suspected or confirmed to be due to Gram-positive p
Thomas Holland, T. Holland, d. huang, P. McLeroth, W. O’Riordan, A. McMAnus, E. Shin, A. Borghei, R. Shukla, T. File, M. Wilcox, A. Torres, M. Dryden, T. Oguri, G. Corey
22 April 2018 - P0602
Differences in the burden of all-cause CAP due to PCV13 serotypes based in the different use of vaccine by regions in Spain (the CAPA study)
Juha Matti Koskinen, P. España, R. Menendez, A. Torres, J. Fernández Villar, J. Marimon, A. Martínez de la Fuente, A. Gil Brusola, F. Marco Reverte, F. Vasallo Vidal, M. Ercibengoa, I. Cifuentes0, C. Méndez0
22 April 2018 - O0591
Efficacy of systemic treatment with linezolid or vancomycin on MRSA biofilm within endotracheal tubes from mechanically ventilated patients with respiratory infection
Laia Fernandez-Barat, L. Fernandez-Barat, A. Motos, M. Panigada, F. Alvarez Lerma, L. Viña, D. Nicolau, G. Li Bassi, A. Ceccato, L. Guerrero, D. Soy, T. Israel, L. Muñoz0, J. Vila, M. Ferrer, A. Torres
21 April 2018 - P0275
Omadacycline versus moxifloxacin in the treatment of adults with community-acquired bacterial pneumonia (CABP): efficacy analysis according to EMA requirements
Antoni Torres, A. Torres, L. Garrity-Ryan, C. Kirsch, J. Steenbergen, P. Eckburg, A. Das, A. Manley, E. Tzanis, P. McGovern
21 April 2018 - P0278
Alternatives to the all-cause mortality (ACM) endpoint for studies of hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP)
Antoni Torres, G. Talbot, A. Das, A. Torres, J. Powers, S. cush, A. Dane, M. Wible, R. Echols, S. Cammarata, J. Rex, T. Fleming, J. Loutit, S. Hoffmann
21 April 2018 - O0181
The impact of non-susceptibility to cefotaxime on the clinical outcome on pneumococcal bacteraemic pneumonia in adult population
Cristina De la Calle, C. De la Calle, C. Cilloniz Campos, F. Marco Reverte, L. Morata, O. Rodríguez Nuñez, J. Martínez Martínez, C. Garcia-Vidal, A. Torres, J. Mensa, A. Soriano
12 April 2016 - P1415
Understanding the lack of simeprevir drug-resistance Q80K detection in hepatitis C virus subtype 1a clade 2 sequences
Allan Peres-da-Silva, Kidd Stephen Peter, Peres-da-Silva Allan, A. Peres-da-Silva, D. Antunes, A. Torres, E. Caffarena, E. Lampe
11 April 2016 - P1240
High concentration of meropenem in endotracheal aspirate does not eradicate susceptible Pseudomonas aeruginosa in mechanically ventilated pigs with pneumonia
Eli Aguilera Xiol, Herpol Margaux, Aguilera Xiol Eli, L. Fernandez-Barat, A. Motos, L. Guerrero, D. Soy, G. Li Bassi, E. Aguilera Xiol, M. Rigol, R. Amaro, A. Torres
Loading ...
+ load more
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.